87 related articles for article (PubMed ID: 29734143)
1. Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma.
Fischer S; Hasan Ali O; Jochum W; Kluckert T; Flatz L; Siano M
Oncol Res Treat; 2018; 41(6):391-394. PubMed ID: 29734143
[TBL] [Abstract][Full Text] [Related]
2. Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature.
Sabbatino F; Marra A; Liguori L; Scognamiglio G; Fusciello C; Botti G; Ferrone S; Pepe S
J Immunother Cancer; 2018 Nov; 6(1):126. PubMed ID: 30458852
[TBL] [Abstract][Full Text] [Related]
3. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient With Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review.
Antonelli JP; Quach M; Mahajan A; Pleva J; Ma VT
J Immunother; 2024 Mar; ():. PubMed ID: 38532708
[TBL] [Abstract][Full Text] [Related]
4. Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy.
González-Cruz C; Muñoz-Couselo E; Ortiz-Velez C; Ferrer B; García-Patos V; Ferrándiz-Pulido C
JAAD Case Rep; 2024 Apr; 46():67-69. PubMed ID: 38577496
[No Abstract] [Full Text] [Related]
5. Metastatic basal cell carcinoma caused by carcinoma misdiagnosed as acne - case report and literature review.
Aydin D; Hölmich LR; Jakobsen LP
Clin Case Rep; 2016 Jun; 4(6):601-4. PubMed ID: 27398205
[TBL] [Abstract][Full Text] [Related]
6. Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics.
Nikanjam M; Cohen PR; Kato S; Sicklick JK; Kurzrock R
Ann Oncol; 2018 Nov; 29(11):2192-2199. PubMed ID: 30219896
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis.
Xie P; Lefrançois P
J Am Acad Dermatol; 2018 Dec; 79(6):1089-1100.e17. PubMed ID: 30003981
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant anti-programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case series.
Ligtenberg KG; Hu JK; Damsky W; Olino K; Kluger H; Clune J; Cowper SE; Panse G; Leventhal J; Weiss SA
JAAD Case Rep; 2020 Jul; 6(7):628-633. PubMed ID: 32613057
[No Abstract] [Full Text] [Related]
10. Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.
Chang ALS; Tran DC; Cannon JGD; Li S; Jeng M; Patel R; Van der Bokke L; Pague A; Brotherton R; Rieger KE; Satpathy AT; Yost KE; Reddy S; Sarin K; Colevas AD
J Am Acad Dermatol; 2019 Feb; 80(2):564-566. PubMed ID: 30145186
[No Abstract] [Full Text] [Related]
11. [Regression of cutaneous basal cell and squamous cell carcinoma under pembrolizumab].
Delaitre L; Martins-Héricher J; Truchot E; Denis D; Prophette B; Maillard H; Bénéton-Benhard N
Ann Dermatol Venereol; 2020 Apr; 147(4):279-284. PubMed ID: 31879092
[TBL] [Abstract][Full Text] [Related]
12. Emerging Nonsurgical Therapies for Locally Advanced and Metastatic Nonmelanoma Skin Cancer.
Chen L; Aria AB; Silapunt S; Migden MR
Dermatol Surg; 2019 Jan; 45(1):1-16. PubMed ID: 30045105
[TBL] [Abstract][Full Text] [Related]
13. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Stratigos AJ; Sekulic A; Peris K; Bechter O; Prey S; Kaatz M; Lewis KD; Basset-Seguin N; Chang ALS; Dalle S; Orland AF; Licitra L; Robert C; Ulrich C; Hauschild A; Migden MR; Dummer R; Li S; Yoo SY; Mohan K; Coates E; Jankovic V; Fiaschi N; Okoye E; Bassukas ID; Loquai C; De Giorgi V; Eroglu Z; Gutzmer R; Ulrich J; Puig S; Seebach F; Thurston G; Weinreich DM; Yancopoulos GD; Lowy I; Bowler T; Fury MG
Lancet Oncol; 2021 Jun; 22(6):848-857. PubMed ID: 34000246
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma.
Jadvar H; In GK
Clin Nucl Med; 2021 Aug; 46(8):e436-e437. PubMed ID: 33512957
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint inhibitors to treat cutaneous malignancies.
Barrios DM; Do MH; Phillips GS; Postow MA; Akaike T; Nghiem P; Lacouture ME
J Am Acad Dermatol; 2020 Nov; 83(5):1239-1253. PubMed ID: 32461079
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors.
Pietrobono S; Stecca B
Cells; 2018 Dec; 7(12):. PubMed ID: 30558232
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy and Its Timing in Advanced Basal Cell Carcinoma Treatment.
Dessinioti C; Stratigos AJ
Dermatol Pract Concept; 2023 Oct; 13(4):. PubMed ID: 37992360
[TBL] [Abstract][Full Text] [Related]
18. The Immune Microenvironment in Basal Cell Carcinoma.
Zilberg C; Lyons JG; Gupta R; Damian DL
Ann Dermatol; 2023 Aug; 35(4):243-255. PubMed ID: 37550225
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma.
Hoashi T; Kanda N; Saeki H
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233269
[TBL] [Abstract][Full Text] [Related]
20. Metastatic basal cell carcinoma to the bone: A case of bone metastasis in uncommon sites.
Nigro O; Chini C; Marcon IGA; De Giorgi A; Bascialla L; Gallerani E; Giaquinto A; De Palma D; Lombardo M
Dermatol Reports; 2022 Sep; 14(3):9267. PubMed ID: 36199894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
